Rockwell Medical, Inc.
RMTI
$0.9559
$0.02612.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 97.73M | 101.49M | 98.92M | 94.37M | 86.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 97.73M | 101.49M | 98.92M | 94.37M | 86.62M |
| Cost of Revenue | 80.27M | 84.01M | 82.19M | 81.69M | 77.45M |
| Gross Profit | 17.46M | 17.48M | 16.72M | 12.69M | 9.17M |
| SG&A Expenses | 16.89M | 16.86M | 15.96M | 15.10M | 14.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.16M | 100.88M | 98.34M | 97.47M | 93.19M |
| Operating Income | 572.00K | 608.00K | 580.00K | -3.09M | -6.57M |
| Income Before Tax | -264.00K | -480.00K | -1.24M | -4.77M | -8.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.26 | -0.48 | -1.24 | -4.77 | -8.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -264.00K | -480.00K | -1.24M | -4.77M | -8.42M |
| EBIT | 572.00K | 608.00K | 580.00K | -3.09M | -6.57M |
| EBITDA | 2.75M | 2.79M | 2.77M | -885.00K | -4.74M |
| EPS Basic | -0.02 | -0.04 | -0.06 | -0.18 | -0.38 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.03 | -0.11 | -0.24 |
| EPS Diluted | -0.03 | -0.04 | -0.07 | -0.18 | -0.39 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.03 | -0.11 | -0.24 |
| Average Basic Shares Outstanding | 128.99M | 124.21M | 119.98M | 115.95M | 102.30M |
| Average Diluted Shares Outstanding | 131.44M | 126.66M | 122.43M | 117.53M | 102.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |